MLchartDataset catalogue

Baloramotide

Term · Oncology and biomedicine · MLC-T-ONC-011870

A genetically engineered synthetic protein, recombinant NY-ESO-1 protein (cancer-testis tumor antigen family) elicits strong humoral and cellular immune responses to NY-ESO-1-expressing cancers and is used to produce specific vaccines to increase the immune response against tumors. NY-ESO-1 epitopes presented by human HLA are recognized by CD4(+) T lymphocytes in patients with NY-ESO-1-expressing melanoma.

Table 1. Record
IdentifierMLC-T-ONC-011870
FieldOncology and biomedicine
Synonymscancer/testis antigen 1, recombinant; recombinant NY-ESO-1 protein
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-011870",
  "term": "Baloramotide",
  "field": "Oncology and biomedicine",
  "definition": "A genetically engineered synthetic protein, recombinant NY-ESO-1 protein (cancer-testis tumor antigen family) elicits strong humoral and cellular immune responses to NY-ESO-1-expressing cancers and is used to produce specific vaccines to increase the immune response against tumors. NY-ESO-1 epitopes presented by human HLA are recognized by CD4(+) T lymphocytes in patients with NY-ESO-1-expressing melanoma.",
  "synonyms": [
    "cancer/testis antigen 1, recombinant",
    "recombinant NY-ESO-1 protein"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/baloramotide/"
}

Record 3,266 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.